HCA
CELG

Heck Capital Advisors’s Celgene Corp CELG Stock Holding History

Heck Capital Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,624
Closed -$360K – 104
2019
Q3 		$360K Buy
3,624
+142
+4% +$13.5K 0.11% 55
2019
Q2 		$322K Buy
3,482
+127
+4% +$12.1K 0.09% 62
2019
Q1 		$317K Buy
3,355
+121
+4% +$10.6K 0.09% 59
2018
Q4 		$207K Sell
3,234
-57
-2% -$4.21K 0.08% 70
2018
Q3 		$295K Sell
3,291
-178
-5% -$15.7K 0.1% 60
2018
Q2 		$276K Buy
3,469
+1,196
+53% +$99.3K 0.1% 58
2018
Q1 		$203K Hold
2,273
– – 0.09% 62
2017
Q4 		$237K Buy
2,273
+1,030
+83% +$116K 0.12% 53
2017
Q3 		$181K Buy
1,243
+38
+3% +$5.18K 0.1% 57
2017
Q2 		$156K Sell
1,205
-92
-7% -$11.3K 0.09% 51
2017
Q1 		$161K Sell
1,297
-60
-4% -$7.18K 0.1% 46
2016
Q4 		$157K Buy
+1,357
New +$151K 0.11% 43

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Heck Capital Advisors's CELG Position: Q4 2019 in Review

Heck Capital Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,624 shares — an estimated $360K sold.

Heck Capital Advisors first reported a position in CELG in Q4 2016 and held it in 12 quarters. The position peaked at $360K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Heck Capital Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Heck Capital Advisors sold 3,624 Celgene Corp shares in Q4 2019, an estimated $360K.
  • Heck Capital Advisors first reported a position in Celgene Corp in Q4 2016 and held it in 12 quarters.
  • Heck Capital Advisors's Celgene Corp position peaked at $360K in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Heck Capital Advisors's 13F filing for Q4 2019, filed 19 May 2025.